The Kentucky Viral Hepatitis Treatment Study

Phase 4

Active, not recruiting

• Conditions: Opioid-Related Disorders; Hepatitis C; Injection Drug Use

• Registration Number: NCT03949764
• Lead Sponsor: Jennifer Havens

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-5-2
• Last Update Posted: 2 September 2024

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 374

Inclusion Criteria

Inclusion Criteria:<br><br> - RNA positive for HCV<br><br> - Perry County residency (verified via ID card showing local address, lease, utility<br> bill, etc.)<br><br> - 18 years of age or older<br><br>Exclusion Criteria:<br><br> - Individuals who are unable to provide consent (to be determined by local study staff<br> in conjunction with our psychiatrist, Dr. Lofwall, a Co-I on the study)<br><br> - Individuals under 18 years of age (study drugs not FDA-approved for those <18)<br><br> - Pregnant women (unable to participate during duration of pregnancy, but encouraged<br> to return following delivery)

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Treatment Uptake;Treatment Completion;Sustained Virologic Response (SVR);Re-infection

Secondary Outcome Measures

Name	Time	Method
Prevalence of HCV;Incidence of HCV